Table 2.
6 Months | 9 Months | 12 Months | 15 Months | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Motive Change | Use | MPI | CUD | Use | MPI | CUD | Use | MPI | CUD | Use | MPI | CUD |
ΔAlcohol | −0.02 | 0.39** | 0.15* | 0.20** | 0.37** | 0.15* | 0.20** | 0.43** | 0.23** | 0.24** | 0.45** | 0.29** |
ΔAltered Perception | 0.30** | 0.37** | 0.23** | 0.40** | 0.46** | 0.29** | 0.50** | 0.49** | 0.32** | 0.42** | 0.53** | 0.37** |
ΔSocial Anxiety | 0.27** | 0.37** | 0.28** | 0.36** | 0.45** | 0.29** | 0.36** | 0.49** | 0.34** | 0.37** | 0.53** | 0.39** |
ΔAvailability | 0.20** | 0.36** | 0.21** | 0.24** | 0.46** | 0.30** | 0.38** | 0.53** | 0.33** | 0.34** | 0.54** | 0.33** |
ΔBoredom | 0.27** | 0.38** | 0.33** | 0.36** | 0.42** | 0.32** | 0.49** | 0.55** | 0.40** | 0.37** | 0.55** | 0.44** |
ΔCelebration | 0.19** | 0.29** | 0.19** | 0.23** | 0.33** | 0.13* | 0.38** | 0.48** | 0.23** | 0.40** | 0.45** | 0.27** |
ΔConformity | 0.20** | 0.48** | 0.30** | 0.29** | 0.44** | 0.24** | 0.35** | 0.57** | 0.14* | 0.35** | 0.60** | 0.38** |
ΔCoping | 0.26** | 0.54** | 0.36** | 0.36** | 0.54** | 0.34** | 0.40** | 0.57** | 0.32** | 0.33** | 0.58** | 0.38** |
ΔEnjoyment | 0.29** | 0.35** | 0.24** | 0.36** | 0.49** | 0.32** | 0.44** | 0.50** | 0.31** | 0.42** | 0.44** | 0.30** |
ΔExperimentation | 0.26** | 0.45** | 0.21** | 0.39** | 0.42** | 0.30** | 0.38** | 0.47** | 0.29** | 0.33** | 0.47** | 0.34** |
ΔSleep | 0.27** | 0.34** | 0.33** | 0.31** | 0.47** | 0.30** | 0.37** | 0.49** | 0.30** | 0.30** | 0.57** | 0.34** |
ΔRelative Low Risk | 0.25** | 0.30** | 0.19** | 0.30** | 0.34** | 0.17* | 0.41** | 0.42** | 0.34** | 0.34** | 0.44** | 0.27** |
Δ. Change in motives from corresponding follow-up being predicted minus baseline. Note: analyses control for baseline level of outcome variable. Positive scores indicate reduction in motives were associated with a reduction in outcomes.
MPI = cannabis problems, CUD = cannabis use disorder symptoms;
p<.01;
p<.05